A Comparative Efficacy of Low-Dose Combined Oral Contraceptives Containing Desogestrel and Drospirenone in Premenstrual Symptoms
Open Access
- 1 January 2013
- journal article
- research article
- Published by Wiley in Obstetrics and Gynecology International
- Vol. 2013, 1-9
Abstract
Objective. To compare the efficacy of low-dose COC containing desogestrel (DSG) with drospirenone (DRSP) in the changes of premenstrual symptoms.Methods. In an open-label randomized controlled trial, 90 women with premenstrual syndrome who required COC were randomly recruited and allocated equally to receive either 6 cycles of 20 micrograms ethinyl estradiol (EE)/150 micrograms DSG (DSG group) or 20 micrograms EE/3 mg DRSP (DRSP group) in 24/4 extended regimen. Analysis of covariance and repeated analysis of variance were used to determine the difference of mean Women's Health Assessment Questionnaire (WHAQ) scores changes between groups, within group, and in premenstrual, menstrual, and postmenstrual phases.Results. Baseline characteristics and WHAQ scores were comparable. At the ends of the 3rd and the 6th cycles, mean WHAQ scores of all the 3 phases in DRSP group showed significant reduction and were significantly lower than those in DSG group. DSG group showed significant reduction in both premenstrual and menstrual phases after the 6th cycle. Adverse effects were comparable in both groups. In conclusion, low-dose COC containing either DSG or DRSP reduced premenstrual symptoms, but the latter showed greater efficacy and earlier reduction.Keywords
Funding Information
- Chulalongkorn University
This publication has 26 references indexed in Scilit:
- Towards a consensus on diagnostic criteria, measurement and trial design of the premenstrual disorders: the ISPMD Montreal consensusArchives of Women's Mental Health, 2011
- Drospirenone: a novel progestinExpert Opinion on Pharmacotherapy, 2007
- Oral contraceptives and mood in women with and without premenstrual dysphoria: a theoretical modelArchives of Women's Mental Health, 2005
- Efficacy of a New Low-Dose Oral Contraceptive With Drospirenone in Premenstrual Dysphoric DisorderObstetrics & Gynecology, 2005
- A comparative study of monophasic oral contraceptives containing either drospirenone 3 mg or levonorgestrel 150 μg on premenstrual symptomsContraception, 2005
- Psychological effect of the oral contraceptive formulation containing 3 mg of drospirenone plus 30 μg of ethinyl estradiolFertility and Sterility, 2004
- Prevalence of menstrual cycle symptom cyclicity and premenstrual dysphoric disorder in a random sample of women using and not using oral contraceptivesActa Obstetricia et Gynecologica Scandinavica, 2000
- Hormone withdrawal symptoms in oral contraceptive usersObstetrics & Gynecology, 2000
- Effect of 21-day and 24-day oral contraceptive regimens containing gestodene (60 μg) and ethinyl estradiol (15 μg) on ovarian activityFertility and Sterility, 1999
- The Influence of Menstrual-Cycle Phase on the Relationship Between Testosterone and AggressionPhysiology & Behavior, 1997